Myelin-associated inhibitors are proteins in the central nervous system that impede nerve regeneration by inhibiting axonal growth, posing challenges for recovery after neural injury. Understanding and targeting these inhibitors is crucial for developing therapies to enhance neural repair and treat conditions like spinal cord injuries and multiple sclerosis.